Enfortumab Vedotin and the Evolving Landscape of Bladder Cancer Care: A Pharmacist’s Guide to ADCs, Combination Therapy, and Expanding Clinical Engagement

- --

- -- 1×

Headliner Embed

Embed code See more options

Share

Facebook X

Subscribe

A landscape overview of enfortumab vedotin’s expanding role across bladder cancer settings — from MIBC to earlier lines of therapy — with a focus on pharmacist-led patient support, AE management, and real-world implementation.

Share

Facebook X

Subscribe

Next

Clinical Approaches for Treatment Intensification in Metastatic Castration-Sensitive Prostate Cancer

Top episodes

Paradigm Shift in Parkinson’s Disease Diagnosis

by MEDCast

Faricimab versus High-Dose Aflibercept for the Treatment of Neovascular AMD and DME

by MEDCast

B Cells as a Treatment Target in Myasthenia Gravis

by MEDCast

•   Report this episode
•   Download audio
•   QRCode